Literature DB >> 9452079

The first pathogenic mitochondrial methionine tRNA point mutation is discovered in splenic lymphoma.

A Lombès1, D Bories, E Girodon, P Frachon, M M Ngo, J Breton-Gorius, M Tulliez, M Goossens.   

Abstract

We describe a novel point mutation in the mitochondrial DNA transfer RNA methionine gene, a G-to-A transition at position 4450, in a patient with a splenic lymphoma with villous lymphocytes. The patient's lymphocytes were remarkable by the presence of large cytoplasmic inclusions demonstrated as abnormal mitochondria by electron microscopy and led to the discovery of the mutation using denaturing gradient gel electrophoresis as a screening procedure. The pathogenic potential of the mutation was clearly established by the following criteria. It was absent in a control population. It involves a nucleotide that is highly conserved along the phylogenetic tree. The mutation was heteroplasmic and, when present in a high proportion, was associated with morphological alterations of the mitochondria, with defects of respiratory chain complexes activities and with a decrease in the mitochondrially encoded cytochrome c oxidase subunit II. Transfer of the mutation in Rho0 cells allowed to demonstrate its association with a severe respiratory chain dysfunction. However, although the pathogenicity of the mutation was clearly demonstrated, its link with the patient disease remained disputable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452079     DOI: 10.1002/humu.1380110158

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  Mitochondrial myopathy with dystrophic features due to a novel mutation in the MTTM gene.

Authors:  Lorenzo Peverelli; Carl A Gold; Ali B Naini; Kurenai Tanji; H Orhan Akman; Michio Hirano; Salvatore Dimauro
Journal:  Muscle Nerve       Date:  2014-08       Impact factor: 3.217

Review 2.  The Importance of Being Modified: The Role of RNA Modifications in Translational Fidelity.

Authors:  Paul F Agris; Amithi Narendran; Kathryn Sarachan; Ville Y P Väre; Emily Eruysal
Journal:  Enzymes       Date:  2017-04-22

3.  Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies.

Authors:  Petr Triska; Kristiyana Kaneva; Daria Merkurjev; Noor Sohail; Marni J Falk; Timothy J Triche; Jaclyn A Biegel; Xiaowu Gai
Journal:  Cancer Res       Date:  2019-02-01       Impact factor: 12.701

4.  Naturally occurring mitochondrial DNA heteroplasmy in the MRL mouse.

Authors:  Paweł Sachadyn; Xiang-Ming Zhang; Lise Desquenne Clark; Robert K Naviaux; Ellen Heber-Katz
Journal:  Mitochondrion       Date:  2008-08-12       Impact factor: 4.160

Review 5.  Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis.

Authors:  Jianxin Lu; Lokendra Kumar Sharma; Yidong Bai
Journal:  Cell Res       Date:  2009-07       Impact factor: 25.617

6.  A disease-causing point mutation in human mitochondrial tRNAMet rsults in tRNA misfolding leading to defects in translational initiation and elongation.

Authors:  Christie N Jones; Christopher I Jones; William D Graham; Paul F Agris; Linda L Spremulli
Journal:  J Biol Chem       Date:  2008-10-03       Impact factor: 5.157

7.  A novel pathogenic m.4412G>A MT-TM mitochondrial DNA variant associated with childhood-onset seizures, myopathy and bilateral basal ganglia changes.

Authors:  Albert Z Lim; Emma L Blakely; Karen Baty; Langping He; Sila Hopton; Gavin Falkous; Kenneth McWilliam; Alison Cozens; Robert McFarland; Robert W Taylor
Journal:  Mitochondrion       Date:  2019-04-22       Impact factor: 4.160

8.  Synthesis and investigation of the 5-formylcytidine modified, anticodon stem and loop of the human mitochondrial tRNAMet.

Authors:  Hrvoje Lusic; Estella M Gustilo; Franck A P Vendeix; Rob Kaiser; Michael O Delaney; William D Graham; Virginia A Moye; William A Cantara; Paul F Agris; Alexander Deiters
Journal:  Nucleic Acids Res       Date:  2008-10-16       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.